IBM Watson Health Demonstrates Global Imaging Market Momentum

IBM Watson Health展示AI肿瘤治疗新成果

2019-12-02 15:00:00 PR Newswire

本文共3512个字,阅读需9分钟

Hardin Memorial Health First to "Go Live" with IBM Watson Imaging Patient Synopsis Imaging Clinical Review 3.0 and Imaging AI Marketplace Launched  Today, at the 105th RSNA Scientific Assembly and Annual Meeting, IBM (NYSE: IBM) Watson Health™ highlighted its recent clients and collaborations for its IBM Watson Health Imaging artificial intelligence (AI) platform, a leading provider of innovative artificial intelligence, enterprise imaging and interoperability solutions available through multiple products and services trusted by medical professionals worldwide. IBM Watson Health will be showcasing its suite of solutions across AI and Machine Learning, Enterprise Imaging, Vendor Neutral Archive, Image Viewing and Sharing, and PACS at the RSNA 105th RSNA Scientific Assembly and Annual Meeting in Chicago, IL between December 1 – 6, 2019. The IBM Watson Health booths are located at the North Hall Level 1 – booth 11332B and North Hall Level 3 — booth 6100. "We are delighted to announce these collaborations at RSNA highlighting our advancements in medical imaging globally," said Anne Le Grand, General Manager, Imaging, Life Sciences and Oncology, IBM Watson Health. "From helping clinicians to identify potential missed findings to seeing a summary view of patient records quickly, our innovative technologies are at the forefront of Watson Health's mission to help enable clinicians to more effectively respond to the world's most pressing health challenges." Hardin Memorial Health First Provider to Use Patient Synopsis   In June 2019, Hardin Memorial Health (HMH) announced it would be the first provider to use IBM Watson Imaging Patient Synopsis, which provides a summary view of patients through analytics and extracts insights from patient records to uncover underlying issues. "Being the first in the world to 'go live' with IBM Watson Imaging Patient Synopsis was an enormous milestone for the HMH team. This tool is already helping to empower HMH to assist care givers in their treatment of patients through the use of this revolutionary platform," said Dennis Johnson, HMH president and CEO. "We look forward to our ongoing collaboration with IBM Watson Health as we continue to care for more than 400,000 Central Kentuckians at our facilities." IBM Watson Health Imaging Clinical Review 3.0 Launches in UK On October 30 2019, Clinical Review 3.0 launched in the UK. The solution is designed to analyze medical imaging studies and their associated reports to identify potential missed findings, helping to facilitate more comprehensive reports, which can potentially lead to higher quality of care for the patient.  IBM Watson Health Imaging has recently engaged with Fortrus Ltd, to grow upon the reseller's strong relationship with the UK public sector, which includes a single supplier outcome-based Managed Services framework. Guerbet Signs Exclusive Development Agreement for AI in Prostate Cancer Guerbet, a global specialist in contrast agents and solutions for diagnostic and interventional imaging, also recently signed an exclusive joint development agreement to develop an artificial intelligence software solution to support prostate cancer diagnostics and monitoring, utilizing MR imaging. This deal extends their earlier collaboration regarding liver cancer signed in January, 2018.  IBM Imaging AI Marketplace Launched The IBM Imaging AI Marketplace is a single-source solution designed to help simplify the complex process of locating, purchasing, deploying and managing the vast array of AI imaging applications. The Imaging AI Marketplace is carefully curated and contains only U.S. Food and Drug Administration (FDA)-cleared solutions alongside Watson Health developed AI solutions. It provides a single location for procurement through deployment, simplifying complex and resource-draining processes, and can be easily accessed via our iConnect™️Enterprise Archive. Vendor Partners: Circle Cardiovascular ImagingDiA Imaging Analysis Ltd. MaxQ AI Quantib BVVIDA LungPrint 4ways Healthcare Limited Adopts IBM Watson Health Imaging Merge PACS™ 4ways, a fast-growing private tele-radiology network in the UK that enables UK-based radiologists to work remotely over a leading technology platform, has committed to underpin its ambitious growth strategy with IBM Watson Health's Merge PACS 8.0 platform, upgrading its current platform to support their business growth. Merge PACS™ is a workflow platform that is designed to help simplify physicians' reading activities and can empower IT leaders with advanced control of the flow of studies throughout the enterprise. "We're committed to constantly investing in and upgrading our IT provision to be able to offer our clients and partners the very best service. That means working with the best tech providers in our space. We've used Merge solutions successfully for many years so continuing with IBM Watson Health imaging solutions was a natural next step. Merge PACS is designed to handle high-enterprise imaging volumes, perform in diverse reading environments, and helps us to scale our delivery of care," said Ajay Chadha, CEO, 4ways. About IBM Watson HealthWatson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health. Watson Health technologies are tackling a wide range of the world's biggest healthcare challenges including cancer, diabetes, drug discovery and more. Learn more at ibm.com/watson/health. About FortrusFortrus operates an outcome based managed service procurement framework for digital transformation across the UK public sector, which has a value of £10 billion. Fortrus is a leading solutions development company focused on user experience software design, providing managed service contracts to a network of NHS customers. About GuerbetGuerbet is a pioneer in the contrast-agent field, with more than 90 years' experience, and is a leader in medical imaging worldwide. It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its four centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €790 million in revenue in 2018. For more information about Guerbet, please visit www.guerbet.com About Hardin Memorial Health HMH is an integrated system of providers and facilities serving approximately 400,000 residents in 10 Central Kentucky counties (Hardin, LaRue, Meade, Breckinridge, Grayson, Nelson, Hart, Bullitt, Green and Taylor). The 300-bed hospital in Elizabethtown, Kentucky includes 270 acute care, 15 psychiatric and 15 skilled nursing beds. Additionally, HMH includes 50+ outpatient facilities across the service area including a Cancer Care Center and Outpatient Surgical Center. There are over 445 physicians and advanced practice clinicians in over 40 specialties and primary care including Hospitalists available 24/7, Emergency and Urgent Care; Cancer, Cardiac, Rehab and Therapy Services; Medical and Surgical Services; Pulmonary Care, Diagnostic Imaging, Ear, Nose and Throat, Plastic and Reconstructive Surgery, Obstetrics including a Level II Neonatal Intensive Care Unit (NICU) and Pediatrics. With 2,700 employees and an active volunteer corps of 140, Hardin Memorial Hospital is the third largest employer in Hardin County. About 4ways4ways is a UK-based market leader in the provision of high-quality remote radiology reporting services. As a trusted partner to the NHS and private healthcare clients, 4ways offers flexible and responsive services in four areas; urgent reporting, routine reporting, advanced super-specialist reporting and clinical audit. Since 2005, clients have relied on 4ways to provide high-quality, cost-effective radiology diagnoses contributing to better clinical decision making and improved patient outcomes. The types of reporting that 4ways covers includes; critical and urgent services with double-read life threat and polytrauma reporting, routine reporting of general, neurological, paediatric, muscular-skeletal, GIT/UIT, gynae, prostate and vascular reporting. 4ways is the market leader in offering advanced remote super-specialist reporting that includes CT-colonography, nuclear medicine, PET-CT, breast MRI, mammography, cardiac CT and cardiac MRI.  IBM Media Contact: Rachel Ford HutmanRachel.Hutman@ibm.com +1 (301) 801-5540 multimedia:http://www.prnewswire.com/news-releases/ibm-watson-health-demonstrates-global-imaging-market-momentum-300966932.html
Hardin Memorial Health 首次“ Go Live ”与 IBM Watson Imaging Patient Synopis Imaging Clinical Review 3.0和 Imaging AI Marketplace 发布 今天,在第十届 RSNA 科学大会和年会上, IBM ( NYSE : IBM ) Watson Health ™强调了其 IBM Watson Health Imaging 人工智能( AI )平台的最新客户和合作,该平台是创新人工智能的领先提供商,企业成像和互操作性解决方案可通过全球医疗专业人员信任的多个产品和服务提供。 IBMWatson Health 将在2019年12月1日至6日于芝加哥召开的 RSNA 第105届 RSNA 科学大会和年度会议上展示其全套解决方案,包括人工智能和机器学习、企业成像、供应商中立档案、图像查看和共享以及 PACS 。IBMWatson 健康展位位于 North Hall 1级-113332B 展位和 North Hall 3级-6100展位。 “我们很高兴在 RSNA 宣布这些合作,强调了我们在全球医学成像方面的进步,” IBMWatson Health 的 Imaging ,生命科学和肿瘤学总经理 AnneLeGrand 说。“从帮助临床医生发现潜在的漏诊结果到快速查看患者记录的摘要,我们的创新技术处于沃森健康使命的前沿,帮助临床医生更有效地应对世界上最紧迫的健康挑战。” Hardin Memorial Health First Provider to Use Patient Synopis 2019年6月, Hardin Memorial Health ( HMH )宣布它将是第一家使用 IBM Watson Imaging Patient Synopis 的供应商,该公司通过分析和从患者记录中提取见解来提供患者的摘要视图,以发现潜在问题。 “成为世界上第一个使用 IBMWatsonImagingPatientSynopsis “生活”的人是 HMH 团队的一个巨大里程碑。HMH 总裁兼首席执行官 DennisJohnson 说:“这个工具已经帮助 HMH 通过使用这个革命性的平台帮助护理人员治疗病人。”“我们期待着与 IBM Watson Health 的持续合作,我们将继续在我们的设施中为超过40万的中央肯塔基人提供服务。” IBM Watson Health Imaging Clinical Review 3.0在英国发布 2019年10月30日,临床评论3.0在英国发布。该解决方案旨在分析医学成像研究及其相关报告,以确定潜在的漏诊结果,帮助促进更全面的报告,这可能导致更高的护理质量的患者。 IBM Watson Health Imaging 最近与 Fortrus Ltd 公司合作,以发展经销商与英国公共部门的强大关系,其中包括单一供应商的基于结果的管理服务框架。 Guerbert 签署前列腺癌人工智能的独家开发协议 全球对比剂和诊断及介入影像解决方案专家 Guerbett 最近还签署了一项独家联合开发协议,开发一种人工智能软件解决方案,以支持前列腺癌诊断和监测,利用磁共振成像。这笔交易延续了他们在2018年1月签署的关于肝癌的早期合作。 IBM Imaging AI Marketplace 启动 IBMImagingAI Marketplace 是一个单一来源的解决方案,旨在帮助简化查找、购买、部署和管理大量人工智能成像应用程序的复杂过程。Imaging AI Marketplace 经过精心策划,仅包含美国食品药品监督管理局(Food and Drug Administration)( FDA )批准的解决方案以及沃森健康开发的 AI 解决方案。它通过部署为采购提供了一个单一位置,简化了复杂和资源耗尽流程,并且可以通过我们的 iConnect ™企业档案库轻松访问。 供应商合作伙伴:环心血管成像分析有限公司 MaxQ AI Quantib BVVIDA LungPrint 4ways Healthcare Limited 采用 IBM Watson Health Imaging 合并 PACS ™ 4way 是英国快速增长的私人远程放射网络,使英国的放射学家能够远程工作在领先的技术平台上,致力于通过 IBMWatson Health 的 Merge PACS 8.0平台支持其雄心勃勃的增长战略,升级其当前平台以支持其业务增长。合并 PACS ™是一个工作流程平台,旨在帮助简化医生的阅读活动,并能增强 IT 领导者对整个企业研究流程的高级控制。 “我们致力于不断投资和升级我们的 IT 服务,以便能够为我们的客户和合作伙伴提供最好的服务。这意味着与我们的领域中最好的技术供应商合作。我们已经成功地使用了合并解决方案多年,因此继续使用 IBMWatson 健康成像解决方案是一个自然的下一步。合并 PACS 的目的是处理高企业成像量,执行在不同的阅读环境,并帮助我们扩大我们提供的护理,说:” AjayChadha ,首席执行官,4way 。 关于 IBMWatson HealthWatson Health 是 IBM 的一个业务部门,致力于人工智能和数据驱动技术的开发和实现,以促进健康。沃森健康技术正在应对全球范围内最大的医疗挑战,包括癌症、糖尿病、药物发现等等。在 ibm 了解更多信息。com / watson / health 。 关于 FortrusFortrus , FortrusFortrus 运营一个基于成果的管理服务采购框架,用于英国公共部门的数字转型,价值100亿英镑。Fortrus 是一家领先的解决方案开发公司,专注于用户体验软件设计,为 NHS 客户网络提供托管服务合同。 关于 GuerberetGuerbert 是造影剂领域的先驱,拥有90多年的经验,是全球医学影像领域的领导者。它为诊断和介入影像提供全方位的医药产品、医疗器械和服务,以改善患者的诊断和治疗。由于8%的收入用于研发,200多名员工分布在法国、以色列和美国的四个中心, Guerbert 是研究和创新的重要投资者。Guerbett ( GBT )在 Euronext Paris ( B 部分–中期资本)上市,2018年实现收入7.9亿欧元。有关 Guerbert 的详细信息,请访问:\160; www.guebet.com 关于哈丁纪念卫生保健是一个综合系统的供应商和设施服务大约40万居民在10个肯塔基中部县(哈丁,拉鲁,米德,布雷克林脊,格雷森,尼尔森,哈特,布拉德,格林和泰勒)。位于肯塔基州 Elizabethtown 的300张床位的医院包括270张急诊室、15张精神科病房和15张熟练的护理病床。此外,卫生保健包括50多个门诊设施横跨服务区,包括一个癌症护理中心和门诊手术中心。有超过445名医生和先进的临床医生在40多个专科和初级护理,包括医院提供24/7,紧急和紧急护理;癌症,心脏,康复和治疗服务;医疗和外科服务;肺护理,诊断成像,耳鼻喉科,整形和重建外科,产科包括二级新生儿重症监护病房( NICU )和儿科。哈丁纪念医院拥有2700名员工和140名志愿者,是哈丁县第三大雇主。 约4ways4way 是英国提供高质量远程放射报告服务的市场领导者。作为 NHS 和私人医疗服务客户的值得信赖的合作伙伴,4way 在四个领域提供灵活和响应的服务:紧急报告、常规报告、高级专家报告和临床审计。自2005年以来,客户依靠4种方式提供高质量、高成本效益的放射诊断,有助于改善临床决策和改善患者结果。 4种报告方式包括:关键和紧急服务,双重阅读生命威胁和多创伤报告,常规报告一般,神经,儿科,肌肉骨骼, GIT / UIT ,妇科,前列腺和血管报告。四是市场领先的提供先进的远程超级专家报告,包括 CT -结肠镜,核医学, PET-CT ,乳房 MRI ,乳房 X 光造影,心脏 CT 和心脏 MRI 。 IBM 媒体联系人: 福特汽车公司.Hutman @ ibm.com +1(301)801-5540 多媒体: http://www.prnewswire.com/news-releases/ibm-watson-health-expression-global-imaging-market-动量-300966932。html

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文